Skip to main navigation Skip to search Skip to main content

Nuclear pore glycoprotein 62 genetic variant rs9523 is associated with clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in lung adenocarcinoma patients

  • Ji Eun Park
  • , Mi Jeong Hong
  • , Shin Yup Lee
  • , Jang Hyuck Lee
  • , Jin Eun Choi
  • , Hyo Gyoung Kang
  • , Sook Kyung Do
  • , Ji Yun Jeong
  • , Kyung Min Shin
  • , Won Kee Lee
  • , Sun Ha Choi
  • , Yong Hoon Lee
  • , Hye Won Seo
  • , Seung Soo Yoo
  • , Jaehee Lee
  • , Seung Ick Cha
  • , Chang Ho Kim
  • , Jae Yong Park

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Nuclear pore glycoprotein 62 genetic variant rs9523 is associated with clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in lung adenocarcinoma patients'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science